The DIVAT cohort

The Immunology and nephrology department of the Nantes University Hospital has developed the DIVAT (standing for computerized and validated data in transplantation) cohort allowing to set up a computer database which includes the monitoring of medical records for kidney and/or pancreas transplant recipients and a software allowing data retrieval from the database for epidemiological analysis.


  • To collect and exchange information.
  • To conduct clinical and epidemiological studies.
  • To communicate and exchange data and results with other academic researchers.
  • To construct partnership with pharmaceutical industries.


  • ​7 main French University Hospitals: Nantes, Paris-Necker, Nancy, Montpellier, Lyon, Paris-Saint Louis and Nice.
  • 300 clinical and biological parameters are collected at 3 months, 6 months, 1 year and then every year.
  • An audit will be carried out once a year.
  • Automatic accuracy controls focus on missing data, inconsistent values, and wrong dates.
  • To create a biocollection database linked to clinical data for centers of Nantes, Necker and Lyon.


Magali Giral
Professeur en Néphrologie

Tél : +33 (0) 2 40 08 74 43

Responsable de l’Unité d’Investigation Clinique - Institut de Transplantation Urologie Néphrologie du CHU de Nantes

Chercheuse - UMR 1064 CRTI « Center for Research in Transplantation and Immunology».

Clarisse Kerleau
Chef de projet

Tél: +33 (0) 2 40 08 74 22

Coordinatrice d’études cliniques – I.T.U.N (Institut de Transplantation Urologie Néphrologie), RTRS Centaure, UMR U1064)

Marine Lorent
Ingénieur Recherche, Docteur en Biostatistique

Chargée des analyses statistiques pour la cohorte EKITE. Domaines de recherche : Modèles de survie, Modèles de survie relative, Méta-analyses d'outils pronostiques

They support DIVAT

En savoir plus sur 

Nous contacter

Tel. +33(0)2 53 00 91 22

Mob. +33(0)6 83 82 26 78


  • LinkedIn Social Icône
  • Facebook
  • Twitter
  • YouTube

Qui sommes-nous ?


Le laboratoire SPHERE (methodS for Patients-centered outcomes and HEalth REsearch, INSERM UMR 1246, Université de NantesUniversité de Tours) et la société IDBC (groupe A2com) ont décidé de créer ensemble le Laboratoire Commun RISCA (Research in Informatics and Statistics for Cohort-based Analyses)